The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Fish Oil Supplementation and Risk of Ventricular Tachycardia and Ventricular Fibrillation in Patients With Implantable Defibrillators: A Randomized Controlled Trial
Abstract
CONTEXT: Clinical studies of omega-3 polyunsaturated fatty acids (PUFAs) have shown a reduction in sudden cardiac death, suggesting that omega-3 PUFAs may have antiarrhythmic effects. OBJECTIVE: To determine whether omega-3 PUFAs have beneficial antiarrhythmic effects in patients with a history of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF). DESIGN AND SETTING: Randomized, double-blind, placebo-controlled trial performed at 6 US medical centers with enrollment from February 1999 until January 2003. PATIENTS: Two hundred patients with an implantable cardioverter defibrillator (ICD) and a recent episode of sustained VT or VF. INTERVENTION: Patients were randomly assigned to receive fish oil, 1.8 g/d, 72% omega-3 PUFAs, or placebo and were followed up for a median of 718 days (range, 20-828 days). MAIN OUTCOME MEASURES: Time to first episode of ICD treatment for VT/VF, changes in red blood cell concentrations of omega-3 PUFAs, frequency of recurrent VT/VF events, and predetermined subgroup analyses. RESULTS: Patients randomized to receive fish oil had an increase in the mean percentage of omega-3 PUFAs in red blood cell membranes from 4.7% to 8.3% (P<.001), with no change observed in patients receiving placebo. At 6, 12, and 24 months, 46% (SE, 5%), 51% (5%), and 65% (5%) of patients randomized to receive fish oil had ICD therapy for VT/VF compared with 36% (5%), 41% (5%), and 59% (5%) for patients randomized to receive placebo (P = .19). In the subset of 133 patients whose qualifying arrhythmia was VT, 61% (SE, 6%), 66% (6%), and 79% (6%) of patients in the fish oil group had VT/VF at 6, 12, and 24 months compared with 37% (6%), 43% (6%), and 65% (6%) of patients in the control group (P = .007). Recurrent VT/VF events were more common in patients randomized to receive fish oil (P<.001). CONCLUSION: Among patients with a recent episode of sustained ventricular arrhythmia and an ICD, fish oil supplementation does not reduce the risk of VT/VF and may be proarrhythmic in some patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It was shown that among patients with a recent episode of sustained ventricular arrhythmia and an implantable cardiac defibrillator, fish oil supplementation might be proarrhythmic (137).”
From The Role of Nutraceuticals in Statin Intolerant Patients (2018) · cites this paper as [137]
Citations
Cites
Cox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease
de Lorgeril, M., Renaud, S., Salen, P., Monjaud, I., Mamelle, N., Martin, J. L., Guidollet, J., Touboul, P., & Delaye, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92580-1 · Cited by 2,122
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Blood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death
Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., & Ma, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012918 · Cited by 1,146
Fish Consumption and Risk of Sudden Cardiac Death
Albert, C. M. (1998) · JAMA · doi:10.1001/jama.279.1.23 · Cited by 990
Siscovick, D. S. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530170043030 · Cited by 920
Kromann, N., & Green, A. (1980) · PubMed · Cited by 854
Cited by
Sorted by citations
Items 301–371 of 371
Arrhythmia Mechanisms in Ischemia and Infarction
Coronel, R., Dun, W., Boyden, P. A., & de Bakker, J. M. T. (2009) · doi:10.1002/9780470561416.ch4 · Cited by 1
Bover, R., Pérez‐Villacastín, J., Pérez‐Castellano, N., Moreno, J., Morales, R., & Macaya, C. (2006) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(06)74825-7 · Cited by 2
Jenkins, N. P., Davidson, N. C., & Bennett, D. H. (2006) · EP Europace · doi:10.1093/europace/eul007 · Cited by 1
Omega-3 Fatty Acids and Cardiovascular Disease
Lee, J. H. (2013) · Journal of Marine Science Research & Development · doi:10.4172/2155-9910.s1-001 · Cited by 1
Diet, Nutrition, and the Prevention of Cardiovascular Disease
Ferland, A., & Eckel, R. H. (2013) · CRC Press eBooks · doi:10.1201/b15294-67 · Cited by 1
Zeghichi, S. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Marchioli, R., & Mozaffarian, D. (2007) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000289278.18298.8b · Cited by 1
Благоприятные эффекты омега-3 жирных кислот при сердечно- сосудистых заболеваниях
Freeman, L. M. (2010) · CyberLeninK (CyberLeninka)
Olshansky, B. (2009) · Elsevier eBooks · doi:10.1016/b978-84-458-1911-1.50030-0
Dietary Omega‐3 Fatty Acids as a Nonpharmacological Antiarrhythmic Intervention
London, B., & Frangiskakis, J. M. (2009) · Wiley eBooks · doi:10.1002/9780470561416.ch21
Mirrahimi, A., Chiavaroli, L., Srichaikul, K., Sievenpiper, J. L., Kendall, C. W. C., & Jenkins, D. J. A. (2011) · InTech eBooks · doi:10.5772/24963
Omega-3 in Antiarrhythmic Therapy
Volpe, M. (2012) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/bf03297630 · Cited by 1
A study of omega-3 fatty acid therapy in patients with nephrotic syndrome
Siddiqui, S. (2008) · Enlighten: Theses (The University of Glasgow)
Nutrition and Cardiovascular Disease: ω‐3 PUFA
Tremoli, E., Minno, M. N. D. D., & Minno, G. D. (2011) · doi:10.1002/9781444318456.ch48
Prevention and Treatment of Life‐Threatening Ventricular Arrhythmia and Sudden Death
Morillo, C. A., & Baranchuk, A. M. (2009) · doi:10.1002/9781444309768.ch40
Sierpita, V. S., & Udani, J. K. (2009) · Elsevier eBooks · doi:10.1016/b978-84-458-1911-1.50036-1
Drugs that affect lipid metabolism
Nestel, P. J. (2012) · Side effects of drugs annual · doi:10.1016/b978-0-444-59499-0.00044-1
Brotons-Cuixart, C. (2005) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(05)71301-3
Fish oil does not improve defibrillation efficacy
Chattipakorn, N., Shinlapawittayatorn, K., Sungnoon, R., & Chattipakorn, S. C. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.11.027
Av, A., Zhelyakov, E. G., & Kuzovlev, O. P. (2013) · Journal of Arrhythmia · doi:10.1016/j.joa.2013.04.008
Wen, H., Zhao, Z., Fefelova, N., Allen, C., Guillaume, N., Xiao, D., Huang, C. Y., Zang, W., Gwathmey, J. K., & Xie, L. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.09.097
Nutritional evidence still lacks consistency
Nestel, P. J. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328012998d
Should we treat all primary prevention patients with statins?
Guthrie, R. M. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0006-x
Omega-3 Fatty Acids: antiarrhythmic, Proarrhythmic Or both?
Raitt, M. H. (2006) · Future Cardiology · doi:10.2217/14796678.2.3.273
Chronic Suppression of Ventricular Tachyarrhythmias in Patients with ICDs
Zawaneh, M. S., & Stambler, B. S. (2010) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2010.06.008
Nodari, S., Metra, M., Milesi, G., Manerba, A., Cesana, B. M., Gheorghiade, M., & Cas, L. D. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6174-7
Omega-3 Fatty Acids and Cardiovascular Disease Prevention: Reality or Mirage?
Shen, J. (2011) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-011-0205-1
Reducing ICD Shocks for Ventricular Arrhythmias
Schoenhard, J. A., & Zei, P. C. (2011) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2011.05.013
Zipes, D. P., Buxton, A. E., Gregoratos, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quiñones, M. A., von Roden, M., & Silka, M. J. (2006)
Omega-3 Fatty Acids: Emerging Role for Cardioprotection
Backes, J. M., & Howard, P. A. (2008) · Hospital Pharmacy · doi:10.1310/hpj4303-178
Nutritional modulation of vascular function.
Zanetti, M., Barazzoni, R., Guarnieri, G., G., L., & I., B. (2008) · ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)
Adler, D. S., Albert, C. M., Albert, M. A., Antman, E. M., Baughman, K. L., Beckman, J. A., Blatt, C. M., Braunwald, E., Cannon, C. P., Chen, M. H., et al. (2006)
Dallongeville, J. (2015) · Cahiers de Nutrition et de Diététique · doi:10.1016/s0007-9960(15)30017-1
Current Approaches to Treatment of Ventricular Arrhythmias in Patients with Coronary Artery Disease
Jacobson, J. T., Iwai, S., & Aronow, W. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802385-3.00012-7
Versari, D., Daghini, E., Salvetti, G., & Salvetti, A. (2008) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/0151642-200815040-00002
Use of Omega-3 Fish Oil Supplementation to Reduce Recurrent Cardiovascular Events
Guthrie, R. M. (2011) · The Physician and Sportsmedicine · doi:10.3810/psm.2011.02.1853
Hold the Fish Oil for Patients with ICDs
Calkins, H. G. (2005) · Journal watch · doi:10.1056/jc200507220000001
Meiss, D., & Olmstead, S. (2009) · CRC Press eBooks · doi:10.1201/9781420067637.ch7
Non-antiarrhythmic Therapies for Cardiac Arrhythmias
DEEDWANIA, P. C., & Lardizabal, J. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00084-3
Effects of Nutrient Supplements and Nutraceuticals on Risk for Cardiovascular Disease
Cao, Y., Zhang, J., & Kris‐Etherton, P. M. (2013) · CRC Press eBooks · doi:10.3109/9781420019667-10
Biological Effects of Alpha-Linolenic Acid
Djoussé, L. (2007) · doi:10.1201/9781420006902-35
Parameters in Humans Dietary Fish and n-3 Fatty Acid Intake and Cardiac Electrocardiographic
Mozaffarian, D., Prineas, R. J., Stein, P. K., & Siscovick, D. S. (2010)
NARRATIVE REVIEW Omega-3 Polyunsaturated Fatty Acids in the Treatment of Kidney Disease
Fassett, R. G., Gobe, G. C., Peake, J. M., & Coombes, J. S. (2010)
Zou, L. (2014) · TSpace (University of Toronto)
Fatahi, S., Haghighatdoost, F., Larijani, B. A., & Azadbakht, L. (2018) · Qom Univ Med Sci J · doi:10.29252/qums.12.9.1
Gavva, E. M., Tsaregorodtsev, D. A., Mamedov, I. S., & Sulimov, V. A. (2012) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2012-4-16-22
Complementary and Alternative Medicine
Thaik, C. M., Moscucci, M. M., Warber, S. L., & Aaronson, K. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-28328-5_34
Fishing for an Association With Sudden Cardiac Death
Siegel, E. R., & Tseng, Z. H. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.3039
Корекція стану регуляторних механізмів серця та працездатності спринтерів
Korytko, Z. (2014) · Спортивна медицина фізична терапія та ерготерапія · doi:10.32652/spmed.2014.2.96-101
(2009) · Wiley eBooks · doi:10.1002/9781444317176.refs
(2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000277985.25720.16
Jones, S. S. (2008) · Springer eBooks · doi:10.1007/978-0-387-76606-5_4
Olshansky, B. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00027-3
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00746-0
Does fish oil really help heart disease?
(2006) · Arbor Clinical Nutrition Updates · doi:10.1017/s1446545000000658
Drugs that affect lipid metabolism
Aursnes, I. (2008) · Side effects of drugs annual · doi:10.1016/s0378-6080(08)00044-5
Effects of Nutrient Supplements and Nutraceuticals on Risk for Cardiovascular Disease
Cao, Y., Zhang, J., & Kris‐Etherton, P. M. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420019667.004
Sierpina, V. S., & Udani, J. K. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2954-0.50040-5
Effects of Nutrient Supplements and Nutraceuticals on Risk for Cardiovascular Disease
Cao, Y., Zhang, J., & Kris‐Etherton, P. M. (2007) · CRC Press eBooks · doi:10.3109/9781420019667-5
ADVERSE CARDIOVASCULAR EFFECTS OF NON-CARDIOVASCULAR DRUGS
(2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53268-8.50009-0
Olshansky, B. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2954-0.50034-x
Harris, W. S., & Jacobson, T. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00026-8
Fish Consumption and Cardio Vascular Diseases in Sri Lanka
Devadawson, C. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24327151256
Guzman, M. B. A. D., Simon, S. A., & Ramirez, M. F. L. (2014) · Philippine journal of cardiology. · doi:10.69944/pjc.f381016945
Cardiovascular health and Omega-3s
Lembke, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-29114-2.00020-9
Class I Antiarrhythmic Drugs: Na+ Channel Blockers
Shenasa, M., & Soleimanieh, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-74046-6_3
ω3-polyunsaturated fatti acids as a tool for cardiovascular prevention
IuA, K., & Александрович, Т. К. (2007) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2007-13-2-160-168
Metadata
- Authors
- Raitt, M. H., Connor, W. E., Morris, C., Kron, J., Halperin, B., Chugh, S. S., McClelland, J., Cook, J., MacMurdy, K., Swenson, R., Connor, S. L., Gerhard, G., Kraemer, D. F., Oseran, D., Marchant, C., Calhoun, D., Shnider, R., & McAnulty, J.
- Affiliations
- Oregon Health & Science University (US)
- Providence St. Vincent Medical Center (US)
- Tufts University (US)
- Oregon State University (US)
- Corresponding author
- Raitt, Merritt H.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-06-15
- Volume
- 293
- Issue
- 23
- Pages
- 2884
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2099859189
- Cited by
- 371
- References
- 25
- Citations by year
- 2025: 3 · 2024: 7 · 2023: 5 · 2022: 4 · 2021: 6 · 2020: 9 · 2019: 3 · 2018: 9 · 2017: 11 · 2016: 11 · 2015: 6 · 2014: 14 · 2013: 19 · 2012: 36
- FWCI
- 40.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl061682-04)
- National Heart, Lung, and Blood Institute (R01HL61682)
- National Center for Research Resources (M01RR000334, 5M01 RR00334)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- omega-3 polyunsaturated fatty acids, ventricular tachycardia, ventricular fibrillation, implantable cardioverter-defibrillator, antiarrhythmic effect, red blood cell membrane fatty acids, recurrent arrhythmia, sudden cardiac death, arrhythmia recurrence, omega-3 deficiency
- MeSH terms
- Aged, Double-Blind Method, Erythrocyte Membrane, Female, Humans, Male, Middle Aged, Prospective Studies, Risk, Ventricular Fibrillation, Fatty Acids, Omega-3, Proportional Hazards Models, Survival Analysis, Defibrillators, Implantable, Tachycardia, Ventricular, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
